Fundraising FoxCoave Therapeutics
Paris, FR · 9 known investors
Find your way into Coave Therapeutics
Sign up to see every warm intro you have to Coave Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Coave Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision. The company focuses on treating retinal vascular diseases and other genetic conditions where traditional gene therapy delivery has been limited.
Investors · 9
How we know: Fund+'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Kurma Partners's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Coave Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Coave Therapeutics do?
- Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision. The company focuses on treating retinal vascular diseases and other genetic conditions where traditional gene therapy delivery has been limited.
- Who are Coave Therapeutics's investors?
- Coave Therapeutics's investors include Fund+, Kurma Partners, Seroba Life Sciences, V-Bio Ventures, Bpifrance, GO Capital, Invus, Novo Holdings and 1 more.
- Where is Coave Therapeutics headquartered?
- Coave Therapeutics is headquartered in Paris, FR.